Your session is about to expire
← Back to Search
Ropivacaine for Postoperative Pain
Study Summary
This trial looks at two ways of administering pain medication after surgery.
- Postoperative Pain
- Surgical Procedure
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- You have a body mass index (BMI) greater than 35.You take more than 30 mg of morphine or similar drugs every day before surgery.You are in prison.You already have nerve problems in the limb that will be operated on.Adults who are in good to moderate health and are having nerve block catheters for pain relief after surgery can join the study.
- Group 1: Continuous Infusion
- Group 2: Intermittent Bolus Infusion
- Drug Has Already Been Approved - The FDA has already approved this drug, and is just seeking more data.
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Pivotal Trial - The final step before approval, pivotal trials feature drugs that have already shown basic safety & efficacy.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Is this opportunity currently accessible to potential participants?
"Unfortunately, the clinicaltrials.gov website reports that this research project is not currently enrolling patients. Initially posted on June 1 2018 and last edited November 1 2022, there are 564 alternative trials searching for participants at present."
Could you elucidate the degree of safety associated with Intermittent Bolus Infusion?
"The safety of Intermittent Bolus Infusion is rated 3, as it has achieved Phase 4 trial status and consequently been granted approval."
What is the quota for participation in this research trial?
"Unfortunately, this trial has concluded its recruitment phase and is no longer accepting patients. The study was initiated on June 1st 2018, with the last update taking place on November 1st 2022. For those looking for other trials to join, there are 497 studies focused on pain management that are currently recruiting as well as 67 intermittent bolus infusion clinical trials actively enrolling participants."
What disease states does Intermittent Bolus Infusion have a proven track record of treating?
"Intermittent Bolus Infusion is commonly employed in anesthesia procedures, but it also has been used to help manage the pain associated with labour and postoperative care."
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger